Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
Objective Stroke is one of the leading causes of disability and death worldwide. Intravenous thrombolytic therapy has been widely recommended as a standard treatment for acute ischemic stroke in most clinical practice guidelines. The authors aimed to report on the efficacy and safety of rt-plasminog...
Saved in:
Main Authors: | Nabil Mohamed (Author), Ahmed Nemr (Author), Hussein ElGharieb (Author), Ahmed Essmat (Author), Elsayed Ahmed (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
by: Soichiro Shibata, et al.
Published: (2022) -
Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
by: Masoud Mehrpour, et al.
Published: (2019) -
Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke
by: Fangfang Zhao, et al.
Published: (2022) -
Thrombolysis and Thrombectomy in Acute Ischemic Stroke
Published: (2023) -
Intravenous thrombolysis in acute ischemic stroke: A prospective cross-sectional observational study in Kashmir
by: Javed Khan, et al.
Published: (2022)